Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk

NCT05433974 is registered in ClinicalTrials.gov with Centre Francois Baclesse, Luxembourg as lead sponsor.

NCT NCT05433974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05433974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk
Lead sponsor
Centre Francois Baclesse, Luxembourg
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2022
Completion date
June 1, 2024
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, radiation toxicity, radiosensitivity